|
- Pegasys: Uses, Dosage, Side Effects, Warnings - Drugs. com
Pegasys is made from human proteins that help the body fight viral infections Pegasys is used alone or with other medicines to treat chronic hepatitis C in adults and children at least 5 years old
- Pegasys Information
In September 2025, access to the 180mcg 1 0ml vial formulation of PEGASYS ® in the U S is expected to become increasingly limited before transitioning to being completely unavailable; however, the 180mcg 0 5ml pre-filled syringe formulation will remain available for eligible patients going forward
- label - Food and Drug Administration
PEGASYS monotherapy is only indicated for the treatment of patients with CHC and compensated liver disease if there are contraindications or significant intolerance to other HCV antiviral drugs
- Peginterferon alfa-2a - Wikipedia
Pegylated interferon alfa-2a, sold under the brand name Pegasys among others, is medication used to treat hepatitis C and hepatitis B [2] For hepatitis C it is typically used together with ribavirin and cure rates are between 24 and 92% [2][3] For hepatitis B it may be used alone [4]
- PRODUCT MONOGRAPH - Roche
Chronic Hepatitis B (CHB) PEGASYS is indicated for the treatment of both HBeAg-positive and HBeAg-negative chronic hepatitis B in: Patients with compensated liver disease, liver inflammation and evidence of viral replication (both cirrhotic and non-cirrhotic disease)
- Pegasys (peginterferon alfa-2a): Uses, Side Effects . . . - WebMD
Find patient medical information for Pegasys (peginterferon alfa-2a) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Pegasys - European Medicines Agency (EMA)
Pegasys is a medicine used to treat chronic (long-term) hepatitis B in adults and children from 3 years of age and chronic hepatitis C in adults and children from 5 years of age
- Pegasys (peginterferon alfa-2a) - MedicineNet
Pegasys (peginterferon alfa-2a) is a prescription medication used to treat adults with chronic hepatitis C infection and compensated liver disease, and children with liver disease Pegasys is sometimes combined with other hepatitis C virus (HCV) antiviral medicines
|
|
|